F6Publishing

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Articles Published Processes

Keyword: Interleukin 28B

Page 1 of 1 ( 11 items )
<<
1
>>

1	Prevalence of IFNL3 rs4803217 single nucleotide polymorphism and clinical course of chronic hepatitis C 6/7/2017 7:22:42 AM \| Browse: 2327 \| Download: 4481
2	Efficacy and safety of telaprevir- and simeprevir-based triple therapies for older patients with chronic hepatitis C 2/17/2017 8:32:00 AM \| Browse: 1241 \| Download: 2245
3	Predictability of IL-28B-polymorphism on protease-inhibitor-based triple-therapy in chronic HCV-genotype-1 patients: A meta-analysis 12/2/2015 12:19:00 PM \| Browse: 1327 \| Download: 2109
4	Role of genetic polymorphisms in hepatitis C virus chronic infection 9/15/2015 6:41:00 PM \| Browse: 1402 \| Download: 2220
5	Interleukin 28B genetic polymorphism and hepatitis B virus infection 9/18/2014 7:49:00 PM \| Browse: 1924 \| Download: 1619
6	Interleukin 28B-related polymorphisms: A pathway for understanding hepatitis C virus infection? 9/12/2014 8:41:00 PM \| Browse: 1561 \| Download: 1685
7	Transmission of hepatitis C virus: Self-limiting hepatitis or chronic hepatitis? 9/12/2014 8:41:00 PM \| Browse: 1262 \| Download: 1189
8	Interleukin 28B polymorphisms as predictor of response in hepatitis C virus genotype 2 and 3 infected patients 9/11/2014 8:39:00 PM \| Browse: 1063 \| Download: 1115
9	IL-28B polymorphisms and treatment response in hepatitis C virus patients with persistently normal alanine aminotransferase 9/10/2014 6:20:00 PM \| Browse: 1176 \| Download: 1294
10	Association of ITPA polymorphism with outcomes of peginterferon-α plus ribavirin combination therapy 9/5/2014 2:19:00 PM \| Browse: 1348 \| Download: 1628
11	Individualization of chronic hepatitis C treatment according to the host characteristics 9/1/2014 2:51:00 PM \| Browse: 1206 \| Download: 1578

Page 1 of 1 ( 11 items )
<<
1
>>

Write to the Help Desk

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.